OurView’s most important price distinction is not between two medications. It is between paying monthly and committing more cash upfront. The platform advertises compounded semaglutide for $109 monthly or $297 prepaid for three months, and compounded tirzepatide for $129 monthly or $357 prepaid for three months. The prominently available $99 and $119 monthly equivalents belong to those prepaid options, not separate monthly payment plans. For someone comparing household expenses, the amount collected matters as much as the advertised monthly rate.
This documentary review examines what those payments appear to buy, what happens before a prescription is issued, and where cancellation may stop future service without returning money already spent. OurView describes itself as a patient-management platform connecting independent medical providers and a pharmacy, rather than directly delivering either service. Sources consulted October 19, 2026 document meaningful pricing and policy details, but not a complete purchase specification: state availability, exact product presentation, renewal mechanics and several refund scenarios remain unresolved.
At a glance
- Compounded semaglutide
- $109 monthly at any prescribed dose, or $297 prepaid for three months, equivalent to $99 monthly. OurView advertises $30 savings, no membership fee and free shipping.Sources: [5]
- Compounded tirzepatide
- $129 monthly at any prescribed dose, or $357 prepaid for three months, equivalent to $119 monthly. OurView advertises $30 savings, no membership fee and free shipping.Sources: [5]
- Platform, not direct care
- OurView says independent providers deliver medical services and a licensed pharmacy partner compounds and dispenses medication. Payment does not guarantee a prescription.
- Cancellation boundary
- The portal permits subscription cancellation before products ship. The policy makes sales final once payment has been charged and the package handed to the carrier.Sources: [4]
- Insurance limitation
- The terms prohibit submitting claims for the telemedicine services to Medicare or other federal, state or private payers; medication insurance billing is not confirmed.Sources: [6]
Start with the amount collected, not the monthly equivalent
OurView presents two payment choices for each advertised compounded medication. Semaglutide is $109 monthly or $297 prepaid for three months; tirzepatide is $129 monthly or $357 prepaid for three months. The three-month prices are alternatives to monthly payment, not mandatory advance purchases. Neither offer is identified in the supplied material as an introductory first-month promotion. That supports reporting the published choices, but not promising that a price will remain unchanged indefinitely.
The provider advertises a $30 saving for either three-month option. Its $99 semaglutide and $119 tirzepatide monthly equivalents require the full corresponding prepayment. A three-month package label does not establish how many vials, doses or shipments a patient receives, nor does it independently establish a minimum treatment commitment. Our guide to monthly and prepaid billing explains why payment period, medication quantity and shipment schedule should be checked separately.
Both medication listings say “Any prescribed dose,” with no membership fee and free shipping. That is a specific pricing claim, not permission to choose a dose or assurance that every requested prescription will be appropriate. The terms also reserve a correction process for an inaccurately listed price: accept the corrected price or forgo the transaction. Obtain the actual checkout amount and billing period before authorizing payment.
| Advertised compounded medication | Payment choice | Important condition |
|---|---|---|
| Semaglutide | $109 monthly | Any prescribed dose; no membership fee; free shipping |
| Semaglutide | $297 prepaid for three months | $99 monthly equivalent; advertised $30 saving |
| Tirzepatide | $129 monthly | Any prescribed dose; no membership fee; free shipping |
| Tirzepatide | $357 prepaid for three months | $119 monthly equivalent; advertised $30 saving |
What the advertised price includes—and does not specify
OurView’s offer includes more than a medication price headline. It advertises a free initial assessment, shipping without an added shipping charge, clinical support and ongoing dosage adjustments without extra charges or additional appointments for those adjustments. Those are useful budget details. However, the documents do not supply a complete itemized fee schedule showing every potential consultation, laboratory requirement, administration supply or other service that could arise during treatment.
The product specification is also incomplete. The commercial plan descriptions identify compounded semaglutide and compounded tirzepatide, but do not confirm their administration route, concentration, dispensed quantity or included administration supplies. An educational article mentions oral and sublingual options as subjects for discussion; that does not establish that either is available through these plans. A price comparison cannot assume an injection, tablet, vial size or particular formulation that the offer itself does not document.
Before paying, request a written description of the exact preparation and presentation, what the first payment covers, and whether anything is billed separately. Our included-costs guide provides a framework for separating medication, care and fulfillment charges. Here, the unresolved issue is not whether OurView publishes prices—it does—but whether the particular prescription and service package match the headline a reader is budgeting around.
The free assessment comes before a clinical decision
The advertised starting process asks patients to choose treatment and answer health and treatment questions through a secure patient journey. A licensed provider then reviews eligibility and determines the treatment plan. OurView describes the assessment as free, without commitment or contracts. Its estimate that getting started takes about three minutes describes entry into the process, not a promise that clinical review, prescribing, pharmacy preparation or delivery will finish within that time.
Payment does not guarantee that a prescription will be written or dispensed. The terms allow a provider to decline care when, in that professional’s judgment, it is medically or ethically inappropriate, including potential misuse. The consulted material does not explain what happens financially if someone pays and then is declined or receives no prescription. That question deserves a direct written answer before either monthly payment or a larger prepaid purchase.
Access boundaries also need individual confirmation. The site requires users to be at least 18; its parent-or-guardian provision does not establish pediatric GLP-1 eligibility. Services are intended for residents of the United States and its territories, but no effective state-by-state availability list is supplied. Complete clinical eligibility criteria, laboratory requirements and contraindication screening are not documented in this evidence. A national audience should not mistake a broadly marketed service for confirmed access in every state.
Follow the money across platform, clinician and pharmacy
OurView says it is a patient-management platform partnered with independent licensed physician networks and a licensed U.S. pharmacy. It expressly says it does not directly provide medical or pharmacy services and is not a state-licensed pharmacy or drug manufacturer. This structure matters when a payment or care question crosses organizational lines: the company coordinating enrollment is not necessarily the entity making a prescribing decision or preparing the medication.
The company attributes its “pharmacy-direct pricing” to working directly with a pharmacy it describes as licensed and nationwide. That is the provider’s commercial explanation, not independent verification of pharmacy licensing or proof that every state has clinical coverage. The commercial page does not name that pharmacy. Although the returns policy lists Boudreaux’s New Drug Store in Lake Charles, Louisiana, that return address does not establish who dispenses every GLP-1 preparation.
The terms offer a meaningful choice: patients may direct their prescription to a pharmacy of their choosing by emailing service@ourviewhealth.com before completing the order. They do not explain whether the advertised package price, shipping arrangement or other inclusions survive that choice. Ask who bills for what if using an outside pharmacy, and identify the actual dispensing pharmacy before purchase rather than assuming the platform’s standard offer transfers unchanged.
Cancellation flexibility is not a prepaid refund promise
OurView advertises “Cancel anytime” and no contracts. Its operational policy says patients can use patient.ourviewhealth.com before products ship to change an address, update payment information or cancel a subscription. These statements describe an ability to end service, but they do not settle what happens to every payment already collected. In particular, the documents do not explain whether cancelling during a prepaid three-month period returns any unused balance.
The refund boundary is more specific: once the payment method has been charged and the package handed to the carrier, all sales are final. OurView’s policy also states that prescription medications cannot be returned after pharmacy dispensing because of state and federal regulations. That is the policy’s explanation, not an independent legal conclusion here. Readers should distinguish stopping a future shipment from reversing a completed sale.
Renewal mechanics remain important gaps. The supplied pages do not clearly establish automatic renewal, the next charge date, advance notices or a numerical cancellation notice deadline. Before selecting prepayment, ask when the next authorization occurs and how cancellation affects medication not yet shipped. Our guide to cancellation and refunds explains why those are separate questions. Retain the confirmation rather than assuming a marketing statement resolves the account’s financial status.
Insurance language limits the reimbursement assumption
OurView’s terms say the services are not health insurance benefits or policies and do not substitute for insurance. More consequentially, ordering requires agreement not to submit claims for the telemedicine services to Medicare, another federal payer, or any state or private payer. This is broader than simply saying the company does not bill insurance directly. Readers should not budget around receiving reimbursement for those telemedicine services after paying out of pocket.
That restriction should not be expanded into an unsupported statement about every medication claim. The consulted sources do not confirm medication insurance billing, HSA or FSA acceptance, or additional discounts beyond the advertised prepayment saving. There is also no documented government-insurance enrollment exclusion to add to the published access rules. Ask specifically about the transaction you intend to make rather than treating insurance acceptance, reimbursement permission and medication coverage as interchangeable.
For broader context, NIDDK notes that some insurance plans cover weight-management medicines and others do not; an individual plan must confirm its own coverage. That general fact does not override OurView’s telemedicine terms. Our insurance and self-pay guide can help organize the separate questions. For this offer, a prudent comparison starts with the documented cash payment and treats any unconfirmed reimbursement or account eligibility as unresolved.
Free shipping still leaves delivery and support questions
OurView advertises discreet packaging, home delivery and fast shipping, without a numerical arrival promise. No documented timeline establishes the separate stages of clinical review, preparation, dispatch and arrival. Free shipping therefore removes a stated shipping charge, not the uncertainty around when medication will reach the patient. For a recurring budget, ask how shipment scheduling relates to billing and what happens if a review or fulfillment delay overlaps the next expected payment.
For damaged medication or a package lost in transit, the policy directs patients to the care team. For lost packages, OurView says it will first work with the carrier to locate and redirect the shipment if appropriate, then reship the order. It does not provide an equally specific remedy for damaged medication. Contact paths are service@ourviewhealth.com and (573) 685-6155; the evidence does not establish support hours or response-time commitments.
Ongoing care is advertised through clinical support and plan adjustments, but follow-up frequency and consultation format are unspecified. The terms describe medication updates and refill reminders by SMS; texting STOP ends that messaging service, not the treatment subscription. They also warn that email and texting are not secure communication methods. Patients should clarify where clinical questions belong, how urgent delivery problems are escalated and how account cancellation is separately confirmed.
A lower price does not answer the product-evidence question
The advertised products are compounded preparations, not documented FDA-approved branded products. FDA states that compounded drugs are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. Nonapproval alone does not demonstrate clinical inequivalence, and it does not by itself validate or condemn OurView. FDA recommends compounded drugs for patients whose medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy.
Clinical research on a drug should not be treated as measured performance for this platform’s preparation. Nothing in the supplied evidence establishes OurView-specific treatment outcomes, or makes its published prices a proxy for clinical quality. FDA has also received reports of compounded-medication measurement or administration errors, some involving hospitalization. Instructions should be clarified with the prescribing clinician or dispensing pharmacist; a price review cannot supply patient dosing directions.
Delivery quality has a concrete clinical boundary even though OurView’s transport specifications are not documented here. FDA explicitly recommends not using an injectable GLP-1 product that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. This advice applies if an injectable is supplied; it does not establish the route of OurView’s advertised plans. A satisfactory purchase explanation should identify both the product and the responsible contact before shipment.
Questions & answers
Can I pay $99 a month for OurView semaglutide without prepaying?
Not under the documented offer. The independent monthly payment is $109 for compounded semaglutide. The $99 figure is the monthly equivalent of paying $297 upfront for three months. Compounded tirzepatide follows the same structure: $129 monthly or $357 prepaid, equivalent to $119 monthly. Neither three-month description specifies the quantity dispensed or number of shipments.
Does OurView charge more when the prescribed dose changes?
The advertised medication prices apply to “Any prescribed dose,” and OurView separately advertises ongoing plan adjustments without extra charges or extra appointments for those adjustments. Those claims do not establish every possible service fee or authorize a patient-selected dose. Confirm the exact prescription, included services and checkout price, particularly if the order differs from the standard advertised package.
What if I pay but the clinician does not prescribe?
OurView expressly says payment does not guarantee a prescription will be written or dispensed, and its providers may decline medically or ethically inappropriate care. The supplied policies do not specify the refund outcome for that situation. Ask whether payment is collected before clinical approval and what amount would be returned if no prescription results.
Will canceling return the unused part of a three-month payment?
The consulted material does not answer that. It allows portal cancellation before shipping and declares sales final after charging and carrier handoff, but does not explain unused prepaid balances. The separate policy allowing possible returns of unopened nonprescription products within 30 days is not a prescription-medication refund right. Obtain a specific answer about the prepaid plan before purchasing.
Can I use my own pharmacy with OurView?
The terms permit directing a prescription to a chosen pharmacy by emailing service@ourviewhealth.com before completing the order. They do not confirm whether the advertised medication price or shipping benefit applies through that pharmacy. Ask for the revised payment arrangement and verify which entity will dispense the preparation; the published return address alone does not identify every GLP-1 dispensing pharmacy.
Who handles a lost or damaged OurView shipment?
Contact the patient care team at service@ourviewhealth.com or (573) 685-6155. For a lost shipment, OurView says it will work with the carrier to locate or redirect it and will reship a lost order. Damaged medication also warrants contact, although the policy does not specify the remedy. No numerical investigation, replacement or arrival timeline is documented.
Our assessment
OurView offers a relatively readable starting price structure: two named compounded medications, monthly and prepaid alternatives, no advertised membership fee, free shipping and no advertised dose-based price increase. The larger uncertainty is what happens around those prices—clinical denial after payment, the exact dispensed product, renewal dates, outside-pharmacy billing and unused quarterly balances. Its cancellation language should not be read as a money-back guarantee. Before paying, obtain a written quote naming the preparation, pharmacy, included services, next charge and cancellation consequences. The monthly option requires less upfront cash than the three-month alternative, while prepayment carries the provider’s advertised saving; neither choice resolves the unanswered service terms. OurView is worth evaluating on those documented conditions, not on price alone.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- OurView — weight loss ↗
- OurView — return refund policy ↗
- OurView — official website ↗
- OurView — terms conditions ↗
- OurView — weight loss/glp 1 medication comparison/tirzepatide vs semaglutide ↗